LABU

Direxion Daily S&P Biotech Bull 3X Shares
*Unless otherwise stated, data provided by FactSet.

LABU Fund Description

LABU provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.

LABU Factset Analytics Insight

LABU is a daily 3x leveraged bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment. It gets its leverage exposure through a portfolio of derivatives contracts that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path-dependent and is likely to be different from 3x the return of the index for the same period. This makes LABU suitable primarily for short-term traders. Over time, compounding effects can lead to profound differences in expected returns relative to the index.

PERFORMANCE [as of 05/26/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
LABU -37.08% -65.03% -83.97% -90.61% -48.93% -33.71% --
LABU (NAV) -36.57% -65.07% -83.88% -90.61% -48.92% -33.65% --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

LABU Summary Data

Direxion
05/28/15
Open-Ended Fund
0.96%
$641.09M
0.09%
N/A

LABU Portfolio Data

0.00%
N/A

LABU Index Data

Equal
Market Cap
N/A

LABU Fund Structure

Yes
Yes
-- / --
N/A
N/A
Low
3
Daily

LABU Tax Exposures

20.00% / 39.60%
--
No

LABU Factset Analytics Block Liquidity

As of 05/27/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of LABU. LABU is rated a 5 out of 5.

LABU Tradability

35,545,453
$315.15M
28,387,130
$326.06M
0.09%
$0.01
0.20%
1.17% / -3.27%
None
94.00%
50,000
567.74
0.01%
--
298,033
$5.78
5